drugset / Trial / NCT06821334
A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)
RandomizedSequentialDouble-blindBasic science
Summary
The goal of this study is to learn how safe MK-6194 is in healthy Chinese adults and how well people tolerate it.
Timeline
- Start
- 2024-04-23
- Primary completion
- 2024-08-09
- Completion
- 2024-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-6194 | Unknown | — | Subcutaneous |
Indications
No indication recorded.